Share Prices & Company Research

Market News

13 Jan 2021 | 21:36

Johnson and Johnson's Covid-19 vaccine approval possible in March

(Sharecast News) - Emergency Use Approval for Johnson&Johnson's Covid-19 vaccine may not arrive before March, potentially a few weeks later than had been hoped for. However, the first batch of late-stage clinical trial data is expected in the last week of January or the first week of February, the drug giant's Chief Scientific Officer, Paul Stoffels, told Bloomberg in an interview.

Officials from the US government's Operation Warp Speed are on record predicting that EUA might arrive in the middle of February, but that timeline might prove to aggressive given J&J's own guidance, the newswire added.

Stoffels reportedly added: "We hope and trust that somewhere in March, we may get that approval."
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 15th January 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.